Catalyst
Slingshot members are tracking this event:
Aerie Pharmaceuticals (AERI) Releases Positive Phase 3 Data on Roclatan for Lowering Intraocular Pressure (IOP) in Patients with Glaucoma or Ocular Hypertension
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 14, 2016
Occurred Source:
https://www.sec.gov/Archives/edgar/data/1337553/000119312516709634/d248088dex991.htm
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Roclatan, Phase 3 Data, Top Line Results, Intraocular Pressure, Glaucoma, Ocular Hypertension, Xalatan
